// App-Quantinova.ai

e13513 : Long-term survivors in glioblastoma patients homogeneously treated with the Stupp regimen, clinical characteristics and MGMT status: Initial results from the GLIOCAT study.

Researchers

Presenter

  • Estela Pineda

Principal Investigators

  • Francesc Alameda

  • Natalia Garcia

  • Eugenia Verger

  • Nuria de la Iglesia

  • Carlos Mesia

  • Oscar Gallego

  • Anna Estival

  • Teresa Pujol

  • Miguel J. Gil Gil

  • Laura Oleaga

  • Jaume Capellades

  • Cristina Carrato

  • Teresa Ribalta

  • Sira Domenech

  • Rafel Fuentes

  • Jose Maria Velarde

  • Carmen Balana

Medical Centers

  • Hospital Clinic Barcelona, Barcelona, Spain

  • Hospital Del Mar, Barcelona, Spain

  • Medical Oncology, Hospital del Mar, Barcelona, Spain

  • IDIBAPS, Badalona, Spain

  • Hospital Clinic Barcelona, Barcelona, Spain

  • Translational Genomics and Targeted Therapeutics in Solid Tumors Lab (IDIBAPS), Medical Oncology. Hospital Clinic Barcelona, Barcelona, Spain

  • ICO Institut Catala d'Oncologia, Barcelona, Spain

  • Hospital De Sant Pau, Barcelona, Spain

  • Medical Oncology Department. Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain

  • Hospital Clinic Barcelona, Barcelona, Spain

  • ICO Institut Catala d'Oncologia, Barcelona, Spain

  • Parc de Salut Mar, Barcelona, SC, Spain

  • Hospital Germans Trias i Pujol, Barcelona, Spain

  • Hospital Germans Trias i Pujol, Barcelona, Spain

  • Institut Catala de Oncologia, Girona, Spain

  • Insitut German Trials i Pujol, Badalona, Spain

  • Institut Catala d'Oncologia, Hospital Universitario German Trias i Pujol, Badalona, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Glioblastoma

Biomarkers

  • O-6-methylguanine DNA methyltransferase

  • Isocitrate dehydrogenase 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved